front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |review

At the study endpoint, favorable effects on lipid profile were observed in the groups treated with ACTOS. In this monotherapy study, the group taking 45 mg once daily showed a statistically significant (P<=0.05) increase in HDL-C vs placebo. The change from baseline was 19.1%. Aronoff S, et al. Diabetes Care. 2000;23:1605-1611.